The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will ...
Cellink AB (publ) (STO:CLNK B) shareholders might be concerned after seeing the share price drop 14% in the last quarter. But looking back over the last year, the returns have actually been rather ...
The Board of Directors of CELLINK AB (publ) (“CELLINK” or the “Company”) has based on the authorization given by the Company’s Annual General Meeting that was held on 18 December 2019, resolved on a ...
One day we’ll replace our old knackered organs with brand new ones that are printed out exclusively for us with a 3D printer. And when we do, we’ll quite possibly use a printer like the Cellink Bio X ...
BLACKSBURG — A lab inside the Virginia Tech Corporate Research Center turned green under the lights of one of Cellink’s 3-D printers on a recent afternoon, a signal that the company’s latest nose was ...
CELLINK today announced its partnership with Made In Space, Inc. (MIS), the industry leader for space manufacturing technologies, to develop advanced bioprinting technology for space. The partnership ...
SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today released its first detailed response to the lawsuit Cellink (NASDAQ Stockholm: BICO) filed against it in ...
Stockholm, April 20, 2020 – Nasdaq (Nasdaq: NDAQ) announces that the trading in Cellink AB’s shares (short name: CLNK B) will commence today on the Nasdaq Stockholm main market. Cellink belongs to the ...
The recent breakthrough in harvesting pig organs for mammalian heart transplants has put the spotlight back on the efforts of many researchers around the world to help solve the world’s organ shortage ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The $130 million building ...
CELLINK has launched the next part of a multiphase bioink expansion. This phase includes the release of two new bioink series, the expansion of three existing bioink series, the release of a new ...
Cellink AB (publ) (STO:CLNK B) shareholders might be concerned after seeing the share price drop 14% in the last quarter. But looking back over the last year, the returns have actually been rather ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback